Diabetic Retinopathy – REEF Trial for Diabetic Macular Edema

Who is the sponsor?

Genentech (Roche), Inc. and California Retina Consultants

Who are the patients?

Individuals with diabetic macular edema unresponsive to previous treatment.

How long is the trial?

One year

What is the enrollment goal for the sponsor?

Fifty patients

What is this study investigating?

To assess the role of ranibizumab therapy in individuals with diabetic macular edema unresponsive to previous medical treatment.